Charles Schwab’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
|
|||||
|
2025
Q1 | $975K | Sell |
|
|||||
|
2024
Q4 | $1.36M | Buy |
|
|||||
|
2024
Q3 | $1.89M | Sell |
|
|||||
|
2024
Q2 | $1.84M | Buy |
|
|||||
|
2024
Q1 | $1.05M | Buy |
|
|||||
|
2023
Q4 | $618K | Buy |
|
|||||
|
2023
Q3 | $640K | Buy |
|
|||||
|
2023
Q2 | $575K | Sell |
|
|||||
|
2023
Q1 | $846K | Sell |
|
|||||
|
2022
Q4 | $3.11M | Buy |
|
|||||
|
2022
Q3 | $4.35M | Buy |
|
|||||
|
2022
Q2 | $4.98M | Buy |
|
|||||
|
2022
Q1 | $5.11M | Buy |
|
|||||
|
2021
Q4 | $12.6M | Buy |
|
|||||
|
2021
Q3 | $16.3M | Buy |
|
|||||
|
2021
Q2 | $15.3M | Buy |
|
|||||
|
2021
Q1 | $17.4M | Sell |
|
|||||
|
2020
Q4 | $17M | Buy |
|
|||||
|
2020
Q3 | $15.8M | Buy |
|
|||||
|
2020
Q2 | $21.5M | Buy |
|
|||||
|
2020
Q1 | $14.9M | Buy |
|
|||||
|
2019
Q4 | $16.9M | Sell |
|
|||||
|
2019
Q3 | $19.1M | Buy |
|
|||||
|
2019
Q2 | $26.7M | Buy |
|
|||||
|
2019
Q1 | $24.3M | Buy |
|
|||||
|
2018
Q4 | $23.1M | Buy |
|
|||||
|
2018
Q3 | $41.2M | Sell |
|
|||||
|
2018
Q2 | $43.3M | Sell |
|
|||||
|
2018
Q1 | $123M | Buy |
|
|||||
|
2017
Q4 | $47.9M | Buy |
|
|||||
|
2017
Q3 | $16.9M | Buy |
|
|||||
|
2017
Q2 | $12.8M | Buy |
|
|||||
|
2017
Q1 | $14.9M | Buy |
|
|||||
|
2016
Q4 | $7.08M | Buy |
|
|||||
|
2016
Q3 | $8.85M | Buy |
|
|||||
|
2016
Q2 | $6.64M | Buy |
|
|||||
|
2016
Q1 | $6.3M | Sell |
|
|||||
|
2015
Q4 | $7.72M | Buy |
|
|||||
|
2015
Q3 | $4.49M | Sell |
|
|||||
|
2015
Q2 | $6.93M | Buy |
|
|||||
|
2015
Q1 | $3.95M | Sell |
|
|||||
|
2014
Q4 | $5.89M | Sell |
|
|||||
|
2014
Q3 | $6.11M | Buy |
|
|||||
|
2014
Q2 | $6.36M | Sell |
|
|||||
|
2014
Q1 | $6.47M | Buy |
|
|||||
|
2013
Q4 | $4.9M | Sell |
|
|||||
|
2013
Q3 | $4.87M | Buy |
|
|||||
|
2013
Q2 | $3.55M | Buy |
|